AllianceBernstein’s Enzo Biochem, Inc. ENZ Stock Holding History

AllianceBernstein’s Portfolio ENZ Stock Details ENZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-56,900	Closed	-$196K	–	3428
2021 Q1	$196K	Sell	56,900 -3,700	-6%	-$11.5K	﹤0.01%	3072
2020 Q4	$153K	Hold	60,600	–	–	﹤0.01%	3049
2020 Q3	$128K	Sell	60,600 -21,300	-26%	-$50.6K	﹤0.01%	3036
2020 Q2	$183K	Buy	81,900 +22,000	+37%	+$56.6K	﹤0.01%	3019
2020 Q1	$152K	Buy	59,900 +24,500	+69%	+$60.2K	﹤0.01%	2867
2019 Q4	$93K	Hold	35,400	–	–	﹤0.01%	3047
2019 Q3	$127K	Hold	35,400	–	–	﹤0.01%	3044
2019 Q2	$119K	Buy	35,400 +3,100	+10%	+$10.9K	﹤0.01%	3055
2019 Q1	$88K	Hold	32,300	–	–	﹤0.01%	3036
2018 Q4	$90K	Hold	32,300	–	–	﹤0.01%	3006
2018 Q3	$133K	Hold	32,300	–	–	﹤0.01%	3051
2018 Q2	$168K	Buy	32,300 +1,000	+3%	+$6.09K	﹤0.01%	3006
2018 Q1	$172K	Sell	31,300 -60,810	-66%	-$428K	﹤0.01%	2885
2017 Q4	$751K	Sell	92,110 -23,040	-20%	-$220K	﹤0.01%	2417
2017 Q3	$1.21M	Hold	115,150	–	–	﹤0.01%	2176
2017 Q2	$1.27M	Buy	+115,150	New	+$1.07M	﹤0.01%	2177
2015 Q2	–	Sell	-3,100	Closed	-$9K	–	3291
2015 Q1	$9K	Hold	3,100	–	–	﹤0.01%	3362
2014 Q4	$14K	Hold	3,100	–	–	﹤0.01%	3274
2014 Q3	$16K	Sell	3,100 -3,100	-50%	-$16.5K	﹤0.01%	3230
2014 Q2	$33K	Buy	+6,200	New	+$26.8K	﹤0.01%	3167

Other funds holding ENZ

HFA

Harbert Fund Advisors Birmingham, Alabama $3.03M AUM 40.55% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

RAM

Roumell Asset Management Chevy Chase, Maryland $53.3M AUM 8.91% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EGA

Evermore Global Advisors Summit, New Jersey $26.3M AUM 7.42% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCA

VIEX Capital Advisors Sunny Isles Beach, Florida $30.9M AUM 55.48% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

AllianceBernstein's ENZ Position: Q2 2021 in Review

AllianceBernstein sold out of Enzo Biochem, Inc. (ENZ) in Q2 2021, closing a stake of 56,900 shares — an estimated $196K sold.

AllianceBernstein first reported a position in ENZ in Q2 2014 and held it in 20 quarters. The position peaked at $1.27M in Q2 2017. 72 funds tracked by Wall St. Rank hold ENZ as of Q2 2021.

AllianceBernstein reported no remaining Enzo Biochem, Inc. position as of Q2 2021 after selling out during the quarter.
AllianceBernstein sold 56,900 Enzo Biochem, Inc. shares in Q2 2021, an estimated $196K.
AllianceBernstein first reported a position in Enzo Biochem, Inc. in Q2 2014 and held it in 20 quarters.
AllianceBernstein's Enzo Biochem, Inc. position peaked at $1.27M in Q2 2017.
72 funds tracked by Wall St. Rank held Enzo Biochem, Inc. as of Q2 2021.

Based on AllianceBernstein's 13F filing for Q2 2021, filed 30 Jul 2021.